Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 44

1.

A model to determine the cost-effectiveness of screening psoriasis patients for psoriatic arthritis.

Iragorri N, Hazlewood G, Manns B, Bojke L, Spackman E; PROMPT study group.

Arthritis Care Res (Hoboken). 2019 Nov 15. doi: 10.1002/acr.24110. [Epub ahead of print]

PMID:
31733035
2.

Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) - a natural experiment (protocol).

Hickman M, Dillon JF, Elliott L, De Angelis D, Vickerman P, Foster G, Donnan P, Eriksen A, Flowers P, Goldberg D, Hollingworth W, Ijaz S, Liddell D, Mandal S, Martin N, Beer LJZ, Drysdale K, Fraser H, Glass R, Graham L, Gunson RN, Hamilton E, Harris H, Harris M, Harris R, Heinsbroek E, Hope V, Horwood J, Inglis SK, Innes H, Lane A, Meadows J, McAuley A, Metcalfe C, Migchelsen S, Murray A, Myring G, Palmateer NE, Presanis A, Radley A, Ramsay M, Samartsidis P, Simmons R, Sinka K, Vojt G, Ward Z, Whiteley D, Yeung A, Hutchinson SJ.

BMJ Open. 2019 Sep 24;9(9):e029538. doi: 10.1136/bmjopen-2019-029538.

3.

A Multicenter, Randomized, Placebo-Controlled Trial of Atorvastatin for the Primary Prevention of Cardiovascular Events in Patients With Rheumatoid Arthritis.

Kitas GD, Nightingale P, Armitage J, Sattar N, Belch JJF, Symmons DPM; TRACE RA Consortium.

Arthritis Rheumatol. 2019 Sep;71(9):1437-1449. doi: 10.1002/art.40892. Epub 2019 Jul 22.

4.

Delays between the onset of symptoms and first rheumatology consultation in patients with rheumatoid arthritis in the UK: an observational study.

Stack RJ, Nightingale P, Jinks C, Shaw K, Herron-Marx S, Horne R, Deighton C, Kiely P, Mallen C, Raza K; DELAY study syndicate.

BMJ Open. 2019 Mar 4;9(3):e024361. doi: 10.1136/bmjopen-2018-024361.

5.

Monitoring the hepatitis C epidemic in England and evaluating intervention scale-up using routinely collected data.

Harris RJ, Harris HE, Mandal S, Ramsay M, Vickerman P, Hickman M, De Angelis D.

J Viral Hepat. 2019 May;26(5):541-551. doi: 10.1111/jvh.13063. Epub 2019 Feb 28.

6.

Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study.

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith C, McHugh N; PROMPT study group.

Rheumatology (Oxford). 2019 Jan 1;58(1):144-148. doi: 10.1093/rheumatology/key286.

PMID:
30202906
7.

Risk of uveitis and inflammatory bowel disease in people with psoriatic arthritis: a population-based cohort study.

Charlton R, Green A, Shaddick G, Snowball J, Nightingale A, Tillett W, Smith CH, McHugh N; PROMPT study group.

Ann Rheum Dis. 2018 Feb;77(2):277-280. doi: 10.1136/annrheumdis-2017-212328. Epub 2017 Nov 1.

PMID:
29092855
8.

Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).

Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A.

Arthritis Rheumatol. 2018 Jan;70(1):109-114. doi: 10.1002/art.40339. Epub 2017 Dec 1.

9.

A Multicenter Nominal Group Study to Rank Outcomes Important to Patients, and Their Representation in Existing Composite Outcome Measures for Psoriatic Arthritis.

Tillett W, Dures E, Hewlett S, Helliwell PS, FitzGerald O, Brooke M, James J, Lord J, Bowen C, de Wit M, Orbai AM, McHugh N; PROMPT study group.

J Rheumatol. 2017 Oct;44(10):1445-1452. doi: 10.3899/jrheum.161459. Epub 2017 Aug 1.

PMID:
28765241
10.

Tetraspanin Tspan9 regulates platelet collagen receptor GPVI lateral diffusion and activation.

Haining EJ, Matthews AL, Noy PJ, Romanska HM, Harris HJ, Pike J, Morowski M, Gavin RL, Yang J, Milhiet PE, Berditchevski F, Nieswandt B, Poulter NS, Watson SP, Tomlinson MG.

Platelets. 2017 Nov;28(7):629-642. doi: 10.1080/09537104.2016.1254175. Epub 2016 Dec 29.

11.

Factors Associated with Transition from Community Settings to Hospital as Place of Death for Adults Aged 75 and Older: A Population-Based Mortality Follow-Back Survey.

Bone AE, Gao W, Gomes B, Sleeman KE, Maddocks M, Wright J, Yi D, Higginson IJ, Evans CJ; OPTCare Elderly.

J Am Geriatr Soc. 2016 Nov;64(11):2210-2217. doi: 10.1111/jgs.14442. Epub 2016 Sep 9.

12.

A large two-centre study in to rates of influenza and pneumococcal vaccination and infection burden in rheumatoid arthritis in the UK.

Subesinghe S, Rutherford AI, Ibrahim F, Harris H, Galloway J.

BMC Musculoskelet Disord. 2016 Aug 4;17:322. doi: 10.1186/s12891-016-1187-4.

13.

How to Motivate Patients with Rheumatoid Arthritis to Quit Smoking.

Harris HE, Tweedie F, White M, Samson K.

J Rheumatol. 2016 Apr;43(4):691-8. doi: 10.3899/jrheum.141368. Epub 2016 Feb 15.

PMID:
26879360
14.

Cognition in Adult Bereavement: Preliminary Findings From Five Hospice Bereavement Focus Groups.

Harris H, Lee C, Yancey G.

J Soc Work End Life Palliat Care. 2015;11(3-4):283-306. doi: 10.1080/15524256.2015.1115801.

PMID:
26654062
15.

Clearance of persistent hepatitis C virus infection in humanized mice using a claudin-1-targeting monoclonal antibody.

Mailly L, Xiao F, Lupberger J, Wilson GK, Aubert P, Duong FHT, Calabrese D, Leboeuf C, Fofana I, Thumann C, Bandiera S, Lütgehetmann M, Volz T, Davis C, Harris HJ, Mee CJ, Girardi E, Chane-Woon-Ming B, Ericsson M, Fletcher N, Bartenschlager R, Pessaux P, Vercauteren K, Meuleman P, Villa P, Kaderali L, Pfeffer S, Heim MH, Neunlist M, Zeisel MB, Dandri M, McKeating JA, Robinet E, Baumert TF.

Nat Biotechnol. 2015 May;33(5):549-554. doi: 10.1038/nbt.3179. Epub 2015 Mar 23.

16.

Increased uptake and new therapies are needed to avert rising hepatitis C-related end stage liver disease in England: modelling the predicted impact of treatment under different scenarios.

Harris RJ, Thomas B, Griffiths J, Costella A, Chapman R, Ramsay M, De Angelis D, Harris HE.

J Hepatol. 2014 Sep;61(3):530-7. doi: 10.1016/j.jhep.2014.05.008. Epub 2014 May 10.

17.

Evidence for sodium metasilicate receptors on the human osteoblast cell surface; spatial localization and binding properties.

Vere KA, Richens JL, Lane JS, Harris HJ, Duggan J, O'Shea P.

Mol Membr Biol. 2013 Dec;30(8):386-93. doi: 10.3109/09687688.2013.843031. Epub 2013 Oct 23.

PMID:
24147954
18.

Production, purification and characterization of recombinant, full-length human claudin-1.

Bonander N, Jamshad M, Oberthür D, Clare M, Barwell J, Hu K, Farquhar MJ, Stamataki Z, Harris HJ, Dierks K, Dafforn TR, Betzel C, McKeating JA, Bill RM.

PLoS One. 2013 May 21;8(5):e64517. doi: 10.1371/journal.pone.0064517. Print 2013.

19.

HRas signal transduction promotes hepatitis C virus cell entry by triggering assembly of the host tetraspanin receptor complex.

Zona L, Lupberger J, Sidahmed-Adrar N, Thumann C, Harris HJ, Barnes A, Florentin J, Tawar RG, Xiao F, Turek M, Durand SC, Duong FH, Heim MH, Cosset FL, Hirsch I, Samuel D, Brino L, Zeisel MB, Le Naour F, McKeating JA, Baumert TF.

Cell Host Microbe. 2013 Mar 13;13(3):302-13. doi: 10.1016/j.chom.2013.02.006.

20.

Early infection events highlight the limited transmissibility of hepatitis C virus in vitro.

Meredith LW, Harris HJ, Wilson GK, Fletcher NF, Balfe P, McKeating JA.

J Hepatol. 2013 Jun;58(6):1074-80. doi: 10.1016/j.jhep.2013.01.019. Epub 2013 Jan 23.

PMID:
23353869

Supplemental Content

Loading ...
Support Center